Posted by Clinical Lab Products | Apr 10, 2005 | Cancer, Miscellaneous |
COLA Announces New QMS Accreditation Program COLA has launched a quality management systems (QMS) accreditation program to assist laboratories faced with the challenge of maintaining a culture of quality. The program is a systems-based management
Read MorePosted by Clinical Lab Products | Jul 12, 2004 | Cancer, Miscellaneous, Osteoporosis |
Roche and Premier Continue Partnership Roche Diagnostics Corp and Premier Purchasing Partners LLP have signed a 3-year agreement in which Roche will continue to provide instruments, reagents, and consumables to Premier members. The contract includ
Read MorePosted by Clinical Lab Products | May 1, 2004 | Cancer, Miscellaneous |
By Marleen and Gary Wolfe The past year was a busy one worldwide for clinical microbiologists as they responded to one medical crisis after another. Outbreaks of new diseases, such as SARS (severe acute respiratory syndrome), and virulent new str
Read MorePosted by Clinical Lab Products | Dec 6, 2003 | Cancer, Miscellaneous, Osteoporosis |
ImmuKnow™: A Pharmacodynamic Assay for Managing Immunosuppressive Drug Therapy
Read MorePosted by Clinical Lab Products | Dec 5, 2003 | Cancer, Miscellaneous |
By Susan L. Taylor, MS, MT (ASCP), MBA In September 2003, the VIDAS® D-Dimer New™ from bioMerieux was approved by the United States Food and Drug Administration (FDA) for use in excluding a diagnosis of deep-vein thrombosis (DVT) when used i
Read More